On the contrary, the OPG, a soluble decoy receptor for RANKL, competitively binds with RANKL, thereby blocking the interaction between RANKL and RANK and benefiting RA treatment (Udagawa et al., 2021). Here, TNFSF11 is linked to rheumatoid arthritis.